Correlation of Urine Albumin/Creatinine Ratio (UACR), High Sensitivity C-Reactive Protein (hsCRP) and N-Terminal Pro Brain Natriuretic Peptide (NT-proBNP) with Atherosclerosis (OxLDL) in Centrally Obese Men
Abstract
BACKGROUND: Obesity is closely associated with atherosclerosis risk and cardiovascular disease. Novel cardiovascular risk biomarkers such as Urine Albumin/Creatinine Ratio (UACR), High Sensitivity C-Reactive Protein (hsCRP) and N-Terminal pro Brain Natriuretic Peptide (NT-proBNP) have been observed to predict cardiovascular disease in the general population. The aim of this study was to observe the correlation of UACR, hsCRP and NT-proBNP with atherosclerosis (OxLDL) in centrally obese men.
METHODS: The study was observational with a cross sectional design done on 76 male subjects aged 30–50 years with central obesity and mean of age of 37 years. Urine albumin was determined by PEG enhanced immunoturbidimetric assay, urine creatinine by Jaffe without deproteinase, hsCRP by chemiluminescent immunometric assay, NT-proBNP by electrochemiluminescence (ECLIA) and OxLDL by ELISA.
RESULTS: There was significant correlation between hsCRP and OxLDL (r=0.230, p=0.046). There was no significant correlation between UACR and OxLDL (r=-0.138, p=0.236), neither between Log NT-proBNP and OxLDL (r=-0.173, p=0.136).
CONCLUSIONS: Atherosclerosis was significantly correlated with hsCRP (low grade inflammation).
KEYWORDS: NT-proBNP, UACR, hsCRP, OxLDL, atherosclerosis
Full Text:
PDFReferences
International Diabetes Federation. Consensus on the metabolic syndrome: definition and treatment. Berlin: IDF; 2005, article.
Montani JP, Carroll JF, Dwyer TM, Antic V, Dulloo AG. Ectopic fat storage in heart, blood vessels and kidneys in the pathogenesis of cardiovascular disease. Int J Obes. 2004; 28: S58-65, CrossRef.
Olsen MH, Hansen TW, Christensen MK, Gustafsson F, Rasmussen S, Wachtell K, et al. Cardiovascular risk prediction by N-terminal pro brain natriuretic peptide and high sensitivity C-reactive protein is affected by age and sex. J Hypertens. 2007; 26: 26-34, CrossRef.
Steinberg D. Low density lipoprotein oxidation and its pathobiological significance. J Bio Chem. 1997; 34: 20963-6, CrossRef.
Heinecke JW. Mechanisms of oxidative damage of low density lipoprotein in human atherosclerosis. Curr Opin Lipidol. 1997; 8: 268-74, CrossRef.
Koenig W, Khuseyinova N. Biomarkers of atherosclerotic plaque instability and rupture. Arterioscler Thromb Vasc Biol. 2007; 27: 15-26, CrossRef.
Tamba S, Nakatsuji H, Kishida K, Noguchi M, Ogawa T, Okauchi Y, et al. Relationship between visceral fat accumulation and urine albumin-creatinine ratio in middle-aged Japanese men. Atherosclerosis. 2010; 211: 601-5, CrossRef.
Furukawa S, Fujita T, Shimabukuro M, Iwaki M, Yukio Y, Nakajima Y, et al. Increased oxidative stress in obesity and its impact on metabolic syndrome. J Clin Invest. 2004; 114: 1752-61, CrossRef.
Satchell SC, Tooke JE. What is the mechanism of microalbuminuria in diabetes: A role for the Glomerular endothelium? Diabetologia. 2008; 51: 714-25, CrossRef.
Weir MR. Microalbuminuria and cardiovascular disease. Clin J Am Soc Nephrol. 2007; 2: 581-90, CrossRef.
Lyon CJ, Law RE, Hsueh WA. Minireview: adiposity, inflammation, and atherogenesis. Endocrinol 2003; 144: 2195-200, CrossRef.
Libby P. Inflammation and cardiovascular disease mechanisms. Am J Clin Nutr. 2006; 83: 456S-60S, PMID.
Fernandes F, Ramires FJA, Buck PC, Almeida IJ, Rabelo R, Dantas SA, et al. N-terminal-pro-brain natriuretic peptide, but not brain natriuretic peptide, is increased in patients with severe obesity. Braz J Med Bio Res. 2007; 40: 153-8, CrossRef.
Szczepaniak LS, Victor RG, Orci L, Unger RH. Forgotten but not gone. The rediscovery of fatty heart, the most common unrecognized disease in America. Circ Res. 2007; 101: 759-67, CrossRef.
Wang TJ, Larson MG, Levy D, Benjamin EJ, Leip EP, Wilson PWF, et al. Impact of obesity on plasma natriuretic peptide levels. J Am Soc Nephrol. 2004; 109: 594-600, CrossRef.
McGavock MJ, Victor RG, Unger RH, Szczepaniak LS. Adiposity of the heart. Ann Intern Med. 2006; 144: 517-24, CrossRef.
Mehta SK, Rame E, Khera A, Murphy AA, Canham RM, Peshock RM, et al. Left ventricular hypertrophy, subclinical atherosclerosis and inflammation. Hypertension. 2007; 49: 1385-91, CrossRef.
DOI: https://doi.org/10.18585/inabj.v3i1.132
Copyright (c) 2011 The Prodia Education and Research Institute
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Indexed by:
The Prodia Education and Research Institute
